DOI:
10.1055/s-00000059
Pneumologie
Issue S 02 ·
Volume 67 ·
December 2013
DOI: 10.1055/s-003-26092
eFirst
Issue
Most Read
Editorial
S97
Seeger, W.:
3rd Research Workshop Pulmonary Hypertension
Extended Abstract
S98
Schermuly, R. T.:
Pulmonary Hypertension: New Preclinical Developments
S99
Berghausen, E. M.;
Janssen, W.;
Vantler, M.;
Alcazar, M. A.;
ten Freyhaus, H.;
Klinke, A.;
Zhao, J. J.;
Schermuly, R. T.;
Rosenkranz, S.:
Genetic and Pharmacological Inactivation of the PI3K Isoform p110α Protects Against Experimental Pulmonary Hypertension
S100
Kojonazarov, B.;
Lang, M.;
Tian, X.;
Kalymbetov, A.;
Weißmann, N.;
Grimminger, F.;
Kretschmer, A.;
Stasch, J.-P.;
Ghofrani, H.-A.;
Seeger, W.;
Schermuly, R. T.:
Effects of sGC-stimulator Riociguat on Pulmonary Vascular and Right Ventricular Remodeling in Severe Pulmonary Arterial Hypertension
S102
Olschewski, H.:
What is Pulmonary Hypertension?
S104
Miera, O.:
Paediatric Pulmonary Hypertension
S106
Grünig, E.;
Grimminger, F.;
Hoeper, M. M.;
Rosenkranz, S.;
Ghofrani, H.-A.:
The Meaning of Riociguat for the Treatment of Pulmonary Arterial Hypertension
S108
Stern, E.;
Mortensen, K.;
Franzen, K.;
Köster, J.;
Reichert, D.;
Dalhoff, K.;
Weil, J.;
Drömann, D.;
Reppel, M.:
Arterial Stiffness in Patients with Pulmonary Hypertension
S110
Münzel, T.:
New Aspects in the Pathophysiology of Cardiac Insufficiency and their Therapeutic Implications
S111
Hamdani, N.;
Linke, W. A.:
Myocardial Titin: The Main Perpetrator in Diastolic LV Dysfunction
S112
Rosenkranz, S.:
Pulmonary Hypertension in Left Heart Failure – Recent Trials
S114
Dinh, W.;
Albrecht-Küpper, B.;
Weimann, G.;
Schäfer, S.:
Partial Adenosine A1-Receptor Agonist – A New Therapeutic Principle for the Treatment of Heart Failure?
S115
Behr, J.:
Pulmonary Hypertension in COPD and Emphysema – Clinical Implications
S117
Weißmann, N.:
Pathomechanisms of Tobacco Smoke Induced Pulmonary Hypertension and Lung Emphysema
S118
ten Freyhaus, H.;
Janssen, W.;
Leuchs, M.;
Berghausen, E. M.;
Vantler, M.;
Schermuly, R. T.;
Tallquist, M. D.;
Rosenkranz, S.:
Protection from Hypoxia-Induced Pulmonary Hypertension by Genetic Ablation of βPDGF-Receptor-Mediated Activation of PI13 Kinase and PLCγ
S119
Weisel, F. C.;
Kloepping, C.;
Pichl, A.;
Sydykov, A.;
Kojonazarov, B.;
Wilhelm, J.;
Roth, M.;
Ridge, K. M.;
Ghofrani, H.-A.;
Schermuly, R. T.;
Grimminger, F.;
Seeger, W.;
Weißmann, N.;
Kwapiszewska, G.:
The Role of AMD-1 in Vascular Remodeling Processes in Pulmonary Hypertension
S121
Guth, S.;
Kramer, F.;
Schulz, A.;
Wiedenroth, C.;
Kramm, T.;
Mayer, E.:
Identifikation and Changes of Biomarkers in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Undergoing Pulmonary Endarterectomy (PEA)
S122
Arias-Loza, P.-A.;
Jung, P.;
Abesser, M.;
Schuh, K.;
Pelzer, T.:
Development and Evaluation of a Rodent Model of Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
S124
Held, M.;
Hesse, A.;
Hübner, G.;
Jany, B.:
Follow-up after Pulmonary Embolism for Early Detection of CTEPH
S126
Ghofrani, H.-A.;
Grimminger, F.;
Halank, M.;
Grünig, E.;
Mayer, E.;
Neurohr, C.;
Wilkens, H.;
Hoeper, M. M.:
Riociguat Therapy for Inoperable Chronic Thromboembolic Pulmonary Hypertension: A Randomised, Double-Blind, Placebo-Controlled Phase III Trial
